Denmark
Every company in the roster headquartered in Denmark.
Every company in the roster headquartered in Denmark.
10 of 10 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Novo NordiskNVO · NYSE | 32 assets: 13 approved, 8 Ph 3, 5 Ph 2, 4 Ph 1, 2 other | repaglinideUS approval withdrawn · Type 2 DiabetesPartial signal | Dec 2026UBT251 · Phase 1 | $174.4B | $4.2BDec 2025 | Cash-flow positive | $7.9B |
GenmabGMAB · Nasdaq | 8 assets: 4 approved, 1 Ph 3, 2 Ph 2, 1 Ph 1 | Rinatabart sesutecan (Rina-S)Phase 3 · Ovarian Cancer | 31 Dec 2026Zenocutuzumab · Phase 2 | $31.8B | — | Cash-flow positive | $1.4B |
ALK-AbellóALK B · Nasdaq Copenhagen | 1 asset: 1 approved | Approved assets only | Apr 2027Epinephrine · Approved | — | — | — | — |
Ascendis Pharma A/SASND · Nasdaq | 2 assets: 2 approved | Approved assets only | Aug 2027palopegteriparatide · Phase 3 | — | $724MDec 2025 | Cash-flow positive | $344M |
GubraGUBRA · Nasdaq Copenhagen | 2 assets: 2 Ph 2 | BI 3034701Phase 2 · ObesityWeak signal | 15 Dec 2026BI 3034701 · Phase 1 | — | — | — | — |
H. LundbeckHLUN.B · Nasdaq Copenhagen | 10 assets: 8 approved, 1 Ph 3, 1 Ph 2 | BexicaserinPhase 3 · EpilepsyPartial signal | 31 Dec 2026Bexicaserin · Phase 3 | — | — | — | — |
Zealand PharmaZEAL · Nasdaq Copenhagen | 6 assets: 2 approved, 2 Ph 3, 1 Ph 2, 1 Ph 1 | survodutidePhase 3 · ObesityReliable signal | 8 Dec 2026survodutide · Phase 1 | — | $2.2BMar 2026 | — | ~$224M |
Antag TherapeuticsPrivate | 1 asset: 1 Ph 2 | AT-7687Phase 2 · Obesity | Feb 2027AT-7687 · Phase 2 | — | — | — | — |
PharmacosmosPrivate | 1 asset: 1 approved | Approved assets only | 30 Apr 2027Ferric derisomaltose · Phase 3 | — | — | — | — |
QuantumCell ApSPrivate | 1 asset: 1 Ph 1 | ACD856Phase 1 · Alzheimer's DiseasePartial signal | None on record | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.